Reduced-Volume Radiotherapy in Nasopharyngeal Carcinoma | Phase 3 Trial
Автор: American Cancer Society Journals
Загружено: 2025-11-07
Просмотров: 3
In February 2025, CA: A Cancer Journal for Clinicians (CA) published its first randomized clinical trial: a multicenter phase III study on reduced-volume vs. conventional radiotherapy after induction chemotherapy in nasopharyngeal carcinoma (NPC).
Radiotherapy is the standard treatment for NPC, but guidelines have traditionally recommended targeting the pre-chemotherapy tumor volume, leading to unnecessary radiation exposure and severe side effects.
This trial led by Jun Ma, MD, from Sun Yat-sen University Cancer Center, found that targeting only the post-chemotherapy tumor volume maintained excellent locoregional control, reduced toxicity, and improved quality of life for patients.
This research represents an important advancement in NPC treatment and a milestone for CA as we expand to include high-impact clinical trial research. As with all articles in CA, this study is free to read, ensuring that clinicians, researchers, and patients everywhere have access to the latest findings in oncology.
Full article: https://acsjournals.onlinelibrary.wil...
Did you know? CA is now accepting proposals for high-impact phase III trials. Learn more: https://acsjournals.onlinelibrary.wil...
Follow CA on social media:
/ cacancerjournal
/ cacancerjournal
/ acs-journals
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
